1376 related articles for article (PubMed ID: 26590714)
1. Targeting the DNA Damage Response in Cancer.
O'Connor MJ
Mol Cell; 2015 Nov; 60(4):547-60. PubMed ID: 26590714
[TBL] [Abstract][Full Text] [Related]
2. Targeting the DNA damage response in oncology: past, present and future perspectives.
Basu B; Yap TA; Molife LR; de Bono JS
Curr Opin Oncol; 2012 May; 24(3):316-24. PubMed ID: 22476188
[TBL] [Abstract][Full Text] [Related]
3. Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.
Darzynkiewicz Z; Traganos F; Wlodkowic D
Eur J Pharmacol; 2009 Dec; 625(1-3):143-50. PubMed ID: 19836377
[TBL] [Abstract][Full Text] [Related]
4. Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice.
Helleday T
Curr Opin Oncol; 2013 Nov; 25(6):609-14. PubMed ID: 24097104
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs, DNA Damage Response, and Cancer Treatment.
He M; Zhou W; Li C; Guo M
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973455
[TBL] [Abstract][Full Text] [Related]
6. Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.
Basourakos SP; Li L; Aparicio AM; Corn PG; Kim J; Thompson TC
Curr Med Chem; 2017; 24(15):1586-1606. PubMed ID: 27978798
[TBL] [Abstract][Full Text] [Related]
7. Targeting DNA Repair in Cancer: Beyond PARP Inhibitors.
Brown JS; O'Carrigan B; Jackson SP; Yap TA
Cancer Discov; 2017 Jan; 7(1):20-37. PubMed ID: 28003236
[TBL] [Abstract][Full Text] [Related]
8. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
[TBL] [Abstract][Full Text] [Related]
9. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
10. The DNA damage response: implications for tumor responses to radiation and chemotherapy.
Goldstein M; Kastan MB
Annu Rev Med; 2015; 66():129-43. PubMed ID: 25423595
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of Response and Resistance to DNA Repair Targeted Therapies.
Stover EH; Konstantinopoulos PA; Matulonis UA; Swisher EM
Clin Cancer Res; 2016 Dec; 22(23):5651-5660. PubMed ID: 27678458
[TBL] [Abstract][Full Text] [Related]
12. Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?
Jacot W; Theillet C; Guiu S; Lamy PJ
Future Oncol; 2015; 11(4):557-9. PubMed ID: 25686112
[No Abstract] [Full Text] [Related]
13. DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer.
Velic D; Couturier AM; Ferreira MT; Rodrigue A; Poirier GG; Fleury F; Masson JY
Biomolecules; 2015 Nov; 5(4):3204-59. PubMed ID: 26610585
[TBL] [Abstract][Full Text] [Related]
14. Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.
Davalli P; Marverti G; Lauriola A; D'Arca D
Oxid Med Cell Longev; 2018; 2018():2389523. PubMed ID: 29770165
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic.
Yap TA; Sandhu SK; Carden CP; de Bono JS
CA Cancer J Clin; 2011; 61(1):31-49. PubMed ID: 21205831
[TBL] [Abstract][Full Text] [Related]
16. Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy.
Aktas BY; Guner G; Guven DC; Arslan C; Dizdar O
Expert Rev Anticancer Ther; 2019 Jul; 19(7):589-601. PubMed ID: 31181965
[No Abstract] [Full Text] [Related]
17. [Synthetic lethality as a new concept for the treatment of cancer].
Herter-Sprie GS; Chen S; Höpker K; Reinhardt HC
Dtsch Med Wochenschr; 2011 Jul; 136(30):1526-30. PubMed ID: 21789751
[TBL] [Abstract][Full Text] [Related]
18. Targeting DNA damage response kinases in cancer therapy.
Gottifredi V
Mutat Res; 2020; 821():111725. PubMed ID: 33157476
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.
Bolderson E; Richard DJ; Zhou BB; Khanna KK
Clin Cancer Res; 2009 Oct; 15(20):6314-20. PubMed ID: 19808869
[TBL] [Abstract][Full Text] [Related]
20. DNA damage response regulation by microRNAs as a therapeutic target in cancer.
Majidinia M; Yousefi B
DNA Repair (Amst); 2016 Nov; 47():1-11. PubMed ID: 27697364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
